Nasacort and Rhinalgia - a phase IV clinical study of FDA data

Summary:

Rhinalgia is reported as a side effect among people who take Nasacort (triamcinolone acetonide), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Celebrex, and have Gastroesophageal reflux disease.

The phase IV clinical study analyzes which people have Rhinalgia when taking Nasacort. It is created by eHealthMe based on reports of 12,923 people who have side effects when taking Nasacort from the FDA, and is updated regularly.

What is Nasacort?

Nasacort has active ingredients of triamcinolone acetonide. It is often used in allergies. eHealthMe is studying from 13,298 Nasacort users. Check the latest studies of Nasacort.

What is Rhinalgia?

Rhinalgia (pain in the nose) is found to be associated with 320 drugs and 409 conditions by eHealthMe. Check the latest studies of Rhinalgia.

On Jul, 16, 2026

12,923 people reported to have side effects when taking Nasacort.
Among them, 33 people (0.26%) have Rhinalgia.

Among these 33 people:

How long have people been on Nasacort when they have Rhinalgia? *

What is the gender of people who have Rhinalgia when taking Nasacort? *

female: 86.21 %
male: 13.79 %

What is the age of people who have Rhinalgia when taking Nasacort? *

What are other drugs people take besides Nasacort? *

Lipitor: 12 people, 36.36%
Celebrex: 12 people, 36.36%
Zovirax: 11 people, 33.33%
Nabumetone: 11 people, 33.33%
Nitrostat: 11 people, 33.33%
Nitroglycerin: 11 people, 33.33%
Niaspan: 11 people, 33.33%
Niacin: 11 people, 33.33%
Nexium: 11 people, 33.33%
Clorazepate Dipotassium: 11 people, 33.33%

What are other side effects people have besides Rhinalgia? *

Headache (pain in head): 12 people, 36.36%
Tinnitus (a ringing in the ears): 11 people, 33.33%
Swallowing Difficulty: 11 people, 33.33%
Fall: 11 people, 33.33%
Sensation Of Foreign Body: 11 people, 33.33%
Excoriation (to tear or wear off the skin of): 11 people, 33.33%
Tardive Dyskinesia (a disorder that involves involuntary movements): 11 people, 33.33%
Dizziness: 10 people, 30.30%
Nasal Discharge (discharge from nose): 10 people, 30.30%
Spinal Osteoarthritis (joint cartilage loss in spine): 10 people, 30.30%

What are the existing conditions these people have? *

Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 11 people, 33.33%
Hypersensitivity: 7 people, 21.21%
Multiple Allergies (allergy to multiple agents): 4 people, 12.12%
Sinus Disorder (disease of sinus): 2 people, 6.06%
Sneezing: 1 person, 3.03%
Sinusitis (inflammation of sinus): 1 person, 3.03%
Osteoporosis (bones weak and more likely to break): 1 person, 3.03%
Dyspnea (difficult or laboured breathing): 1 person, 3.03%
Dry Eyes (lack of adequate tears): 1 person, 3.03%
Asthma: 1 person, 3.03%

* Approximation only. Some reports may have incomplete information.

Do you take Nasacort and have Rhinalgia?

- Check whether Rhinalgia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Nasacort:

Nasacort (13,298 reports)

Rhinalgia treatments and more:

Rhinalgia (2,701 reports)

Browse all side effects of Nasacort:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Rhinalgia:

Rhinalgia (320 drugs)

Browse all the conditions that are associated with Rhinalgia:

Rhinalgia (409 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on triamcinolone acetonide (the active ingredients of Nasacort) and Nasacort (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.